PL1789412T3 - Krystaliczna zasada alfuzosyny - Google Patents
Krystaliczna zasada alfuzosynyInfo
- Publication number
- PL1789412T3 PL1789412T3 PL04770711T PL04770711T PL1789412T3 PL 1789412 T3 PL1789412 T3 PL 1789412T3 PL 04770711 T PL04770711 T PL 04770711T PL 04770711 T PL04770711 T PL 04770711T PL 1789412 T3 PL1789412 T3 PL 1789412T3
- Authority
- PL
- Poland
- Prior art keywords
- alfuzosin base
- hours
- crystalline
- base
- solution
- Prior art date
Links
- WNMJYKCGWZFFKR-UHFFFAOYSA-N alfuzosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(C)CCCNC(=O)C1CCCO1 WNMJYKCGWZFFKR-UHFFFAOYSA-N 0.000 title abstract 4
- 229960004607 alfuzosin Drugs 0.000 title abstract 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 6
- 239000007787 solid Substances 0.000 abstract 2
- 238000004128 high performance liquid chromatography Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000010992 reflux Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Silicon Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04770711A EP1789412B1 (en) | 2004-09-16 | 2004-09-16 | Crystalline alfuzosin base |
| PCT/IN2004/000292 WO2006030449A1 (en) | 2004-09-16 | 2004-09-16 | Crystalline alfuzosin base |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1789412T3 true PL1789412T3 (pl) | 2008-10-31 |
Family
ID=36059740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04770711T PL1789412T3 (pl) | 2004-09-16 | 2004-09-16 | Krystaliczna zasada alfuzosyny |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20070100143A1 (pl) |
| EP (1) | EP1789412B1 (pl) |
| AT (1) | ATE394395T1 (pl) |
| DE (1) | DE602004013644D1 (pl) |
| ES (1) | ES2305848T3 (pl) |
| PL (1) | PL1789412T3 (pl) |
| WO (1) | WO2006030449A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005019227A1 (en) * | 2003-08-22 | 2005-03-03 | Orchid Chemicals & Pharmaceuticals Ltd | Process for the preparation of cephalosporin antibiotic |
| WO2006090268A2 (en) * | 2005-02-28 | 2006-08-31 | Glenmark Pharmaceuticals Limited | Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin |
| US20070105880A1 (en) * | 2005-11-08 | 2007-05-10 | Torrent Pharmaceuticals Limited | Process for the preparation of alfuzosin |
| US20090069562A1 (en) * | 2005-12-26 | 2009-03-12 | Joseph Prabahar Koilpillai | Process for the preparation of alfuzosin |
| WO2008015525A2 (en) * | 2006-07-31 | 2008-02-07 | Orchid Chemicals & Pharmaceuticals Limited | An improved process for the preparation of alfuzosin hydrochloride |
| WO2007063556A2 (en) * | 2006-12-07 | 2007-06-07 | Msn Laboratories Limited | An improved and industrial process for the preparation of alfuzosin hydrochloride and its novel polymorphs |
| EP2152697A2 (en) | 2007-05-04 | 2010-02-17 | Actavis Group PTC EHF | Process for the preparation of alfuzosin and salts thereof |
| IT1390760B1 (it) * | 2008-07-21 | 2011-09-23 | Lundbeck Pharmaceuticals Italy Spa | Metodo di preparazione di alfuzosin cloridrato anidro |
| CN108069945A (zh) * | 2017-12-31 | 2018-05-25 | 威海贯标信息科技有限公司 | 一种阿夫唑嗪新晶型 |
| CN114874223B (zh) * | 2022-05-25 | 2023-12-22 | 宁夏东吴农化股份有限公司 | 一种从噁二嗪废水中提取乌洛托品的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2421888A1 (fr) * | 1978-02-06 | 1979-11-02 | Synthelabo | Amides d'alkylene-diamines et leur application en therapeutique |
| US4354921A (en) * | 1981-07-27 | 1982-10-19 | Texaco Inc. | Solvent dewaxing process |
| US4668768A (en) * | 1985-11-25 | 1987-05-26 | General Electric Company | Anti-solvent precipitation process for isolating polymers from solution |
| JPH07206857A (ja) * | 1993-12-28 | 1995-08-08 | Synthelabo Sa | アルフゾシン塩酸塩の二水和物 |
| US7927613B2 (en) * | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| GB0605688D0 (en) * | 2006-03-21 | 2006-05-03 | Novartis Ag | Organic compounds |
| US7923026B2 (en) * | 2006-10-20 | 2011-04-12 | Solvay Pharmaceuticals B.V. | Embedded micellar nanoparticles |
-
2004
- 2004-09-16 US US10/571,744 patent/US20070100143A1/en not_active Abandoned
- 2004-09-16 AT AT04770711T patent/ATE394395T1/de active
- 2004-09-16 ES ES04770711T patent/ES2305848T3/es not_active Expired - Lifetime
- 2004-09-16 WO PCT/IN2004/000292 patent/WO2006030449A1/en active IP Right Grant
- 2004-09-16 EP EP04770711A patent/EP1789412B1/en not_active Expired - Lifetime
- 2004-09-16 PL PL04770711T patent/PL1789412T3/pl unknown
- 2004-09-16 DE DE602004013644T patent/DE602004013644D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE394395T1 (de) | 2008-05-15 |
| EP1789412A1 (en) | 2007-05-30 |
| EP1789412B1 (en) | 2008-05-07 |
| WO2006030449A1 (en) | 2006-03-23 |
| ES2305848T3 (es) | 2008-11-01 |
| US20070100143A1 (en) | 2007-05-03 |
| DE602004013644D1 (de) | 2008-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2555804A1 (en) | Polymorphic form of imatinib mesylate and a process for its preparation | |
| CA2610105C (en) | Process for the synthesis of organic compounds | |
| PL1789412T3 (pl) | Krystaliczna zasada alfuzosyny | |
| MX2008008447A (es) | Proceso para la preparacion de imatinib. | |
| WO2009000441A8 (en) | Processes for the preparation of pyrazoles | |
| WO2007062002A3 (en) | Fluorescent brighteners and compositions thereof, methods of preparation and uses | |
| WO2005107462A3 (en) | Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate | |
| TW200726750A (en) | Stilbene derivatives, light-emitting element and light-emitting device | |
| MY133471A (en) | Process for the preparation of racemic citalopram and s-or r-citalopram by separation of a mixture of r-and s-citalopram | |
| MY134921A (en) | Process for the industrial synthesis of strontium ranelate and its hydrates | |
| MX2007004638A (es) | Proceso para la preparacion de pirazoles. | |
| CN105037236B (zh) | 瑞博西尼中间体及其制备方法 | |
| MX2009010243A (es) | Compuestos de quinolina apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6. | |
| TWI371449B (en) | Conversion of 2-pyrazolines to ryrazoles using bromine | |
| TW200609203A (en) | Preparation of semicarbazones | |
| WO2005080329A3 (en) | Process for manufacture of racemic carvedilol | |
| MX2008000011A (es) | Procesos para preparar derivados de pirazol-o-glucosido y nuevos intermediarios de dichos procesos. | |
| ES2452940T3 (es) | Procedimiento novedoso de preparación de base de imatinib | |
| EP1834943A4 (en) | PROCESS FOR PREPARING AROMATIC DICARBOXYLIC ACIDS | |
| SI1558560T1 (sl) | Postopek za pripravo 2,6-dihalo-para-trifluorometilanilina | |
| WO2007017893A3 (en) | Preparation of novel crystalline form of perindopril erbumine monohydrate | |
| IL149526A0 (en) | Process for the preparation of ketimines | |
| JP2003512370A5 (pl) | ||
| AU2003261853A1 (en) | Process for preparing azo compound | |
| WO2001027092A3 (en) | Process to prepare aryltriazolinones and novel intermediates thereto |